Chlamydophila psittaci transmission from pet birds to humans

• Published in: Emerging infectious diseases Vol. 13; no. 7; pp. 1108 - 1110
• Main Authors: Vanrompay, Daisy, Harkinezhad, Taher, van de Walle, Marijke, Beeckman, Delphine, van Droogenbroeck, Caroline, Verminnen, Kristel, Leten, Ruud, Martel, An, Cauwerts, Katty
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01.07.2007; Centers for Disease Control and Prevention
• Subjects: Animal Husbandry; Animal Technicians; Animals; Anti-Bacterial Agents - therapeutic use; Aves; Bacterial Vaccines - administration & dosage; Belgium; Bird Diseases - transmission; Chlamydophila psittaci; Chlamydophila psittaci - drug effects; Chlamydophila psittaci - genetics; Chlamydophila psittaci - pathogenicity; Disease transmission; Disease Transmission, Infectious; Dispatch; DNA, Bacterial - chemistry; DNA, Bacterial - genetics; Drug Resistance, Bacterial; Environmental Exposure; Feces - microbiology; Genotype; genotyping; Humans; Occupational Diseases - epidemiology; Occupational Diseases - microbiology; Occupational Diseases - prevention & control; Parrots; PCR; pet bird; Psittaciformes; Psittaciformes - microbiology; psittacosis; Psittacosis - drug therapy; Psittacosis - transmission; Psittacosis - veterinary; Zoonoses; zoonosis; Belgium
• ISSN: 1080-6040; 1080-6059
• DOI: 10.3201/eid1307.070074

We studied zoonotic transmission of Chlamydophila psittaci in 39 breeding facilities for Psittaciformes (cockatoos, parrots, parakeets, lories) that frequently used antimicrobial drugs. Genotypes A or E/B were detected in 14.9% of humans at these facilities. Information on antimicrobial drug use in Psittaciformes and a C. psittaci vaccine are urgently required.